Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FLTM7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,804.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The delivery order, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in an unrestricted procurement environment. DMS Pharmaceutical Group is the prime contractor with no identified subcontractors on this award.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The parent IDC, awarded in November 2025 with a $500 million ceiling and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to supply a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables to military medical facilities. DMS Pharmaceutical Group's established performance history on numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FLTM7?
SPE2DR26FLTM7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FLTM7 worth?
The government has obligated $19,805 on SPE2DR26FLTM7.
Is contract SPE2DR26FLTM7 an order under another contract?
Yes. SPE2DR26FLTM7 is a delivery order under SPE2DR25D9766, an indefinite delivery contract.
Was contract SPE2DR26FLTM7 competed?
The extent of competition for SPE2DR26FLTM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award